Bank of America’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-74,558
| Closed | -$4.1M | – | 8597 |
|
|
2022
Q2 | $4.1M | Buy |
74,558
+71,444
| +2,294% | +$3.75M | ﹤0.01% | 3608 |
|
|
2022
Q1 | $100K | Buy |
3,114
+2,498
| +406% | +$71.7K | ﹤0.01% | 6869 |
|
|
2021
Q4 | $13K | Buy |
+616
| New | +$13.6K | ﹤0.01% | 7650 |
|
|
2020
Q1 | – | Sell |
-128
| Closed | -$2K | – | 7418 |
|
|
2019
Q4 | $2K | Sell |
128
-1,093
| -90% | -$14.3K | ﹤0.01% | 6916 |
|
|
2019
Q3 | $19K | Buy |
1,221
+853
| +232% | +$16.3K | ﹤0.01% | 6596 |
|
|
2019
Q2 | $8K | Sell |
368
-294
| -44% | -$14.2K | ﹤0.01% | 6775 |
|
|
2019
Q1 | $45K | Buy |
+662
| New | +$42.5K | ﹤0.01% | 6241 |
|
|
2017
Q4 | – | Sell |
-25
| Closed | -$2K | – | 7354 |
|
|
2017
Q3 | $2K | Hold |
25
| – | – | ﹤0.01% | 6884 |
|
|
2017
Q2 | $1K | Buy |
25
+15
| +150% | +$766 | ﹤0.01% | 6853 |
|
|
2017
Q1 | $1K | Sell |
10
-204
| -95% | -$11.9K | ﹤0.01% | 6891 |
|
|
2016
Q4 | $13K | Sell |
214
-29
| -12% | -$1.81K | ﹤0.01% | 6484 |
|
|
2016
Q3 | $18K | Sell |
243
-156
| -39% | -$12.1K | ﹤0.01% | 6180 |
|
|
2016
Q2 | $32K | Buy |
399
+214
| +116% | +$40.8K | ﹤0.01% | 6041 |
|
|
2016
Q1 | $50K | Buy |
185
+16
| +9% | +$5.11K | ﹤0.01% | 5795 |
|
|
2015
Q4 | $101K | Buy |
169
+161
| +2,013% | +$109K | ﹤0.01% | 5718 |
|
|
2015
Q3 | $7K | Buy |
+8
| New | +$9.02K | ﹤0.01% | 6686 |
|
Other funds holding SRRA
Bank of America's SRRA Position: Q3 2022 in Review
Bank of America sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 74,558 shares — an estimated $4.1M sold.
Bank of America first reported a position in SRRA in Q3 2015 and held it in 16 quarters. The position peaked at $4.1M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.
- Bank of America reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Bank of America sold 74,558 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $4.1M.
- Bank of America first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 16 quarters.
- Bank of America's Sierra Oncology, Inc. Common Stock position peaked at $4.1M in Q2 2022.
- 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.
Based on Bank of America's 13F filing for Q3 2022, filed 14 Nov 2022.